Movsesyan VA et al. |
Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. |
2004 |
Cell Death Differ. |
pmid:15375383
|
Maccarrone M and Finazzi-Agró A |
The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. |
2003 |
Cell Death Differ. |
pmid:12934069
|
Overton HA et al. |
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. |
2006 |
Cell Metab. |
pmid:16517404
|
Oddi S et al. |
Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes. |
2005 |
Cell. Mol. Life Sci. |
pmid:15723173
|
Valenti M et al. |
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. |
2004 |
Cell. Mol. Life Sci. |
pmid:15095014
|
Hermann H et al. |
Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. |
2003 |
Cell. Mol. Life Sci. |
pmid:12737320
|
Oddi S et al. |
Evidence for the intracellular accumulation of anandamide in adiposomes. |
2008 |
Cell. Mol. Life Sci. |
pmid:18213445
|
Catani MV et al. |
Anandamide extends platelets survival through CB(1)-dependent Akt signaling. |
2010 |
Cell. Mol. Life Sci. |
pmid:19936621
|
Sarker KP and Maruyama I |
Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. |
2003 |
Cell. Mol. Life Sci. |
pmid:12861385
|
Laviolette SR and Grace AA |
The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. |
2006 |
Cell. Mol. Life Sci. |
pmid:16699809
|
van der Stelt M et al. |
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. |
2006 |
Cell. Mol. Life Sci. |
pmid:16732431
|
Gasperi V et al. |
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. |
2007 |
Cell. Mol. Life Sci. |
pmid:17187172
|
Dickason-Chesterfield AK et al. |
Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. |
2006 Jul-Aug |
Cell. Mol. Neurobiol. |
pmid:16736384
|
Stark S et al. |
Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells. |
1997 |
Cell. Mol. Neurobiol. |
pmid:9353590
|
Bobbala D et al. |
Effect of anandamide in Plasmodium Berghei-infected mice. |
2010 |
Cell. Physiol. Biochem. |
pmid:20798520
|
Jenkin KA et al. |
Role for cannabinoid receptors in human proximal tubular hypertrophy. |
2010 |
Cell. Physiol. Biochem. |
pmid:21220919
|
Bentzen PJ and Lang F |
Effect of anandamide on erythrocyte survival. |
2007 |
Cell. Physiol. Biochem. |
pmid:17975305
|
Fimiani C et al. |
Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. |
1999 |
Cell. Signal. |
pmid:10353693
|
Greco R et al. |
Alterations of the endocannabinoid system in an animal model of migraine: evaluation in cerebral areas of rat. |
2010 |
Cephalalgia |
pmid:19515121
|
Cupini LM et al. |
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. |
2006 |
Cephalalgia |
pmid:16472333
|
Rubino T et al. |
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. |
2008 |
Cereb. Cortex |
pmid:17921459
|
Hanus LO |
Discovery and isolation of anandamide and other endocannabinoids. |
2007 |
Chem. Biodivers. |
pmid:17712821
|
Okamoto Y et al. |
Biosynthetic pathways of the endocannabinoid anandamide. |
2007 |
Chem. Biodivers. |
pmid:17712822
|
Lehtonen M et al. |
Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes. |
2008 |
Chem. Biodivers. |
pmid:19035572
|
Oddi S et al. |
Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins. |
2009 |
Chem. Biol. |
pmid:19481477
|
Ahn K et al. |
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. |
2009 |
Chem. Biol. |
pmid:19389627
|
Godlewski G et al. |
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. |
2010 |
Chem. Biol. |
pmid:21095576
|
Shekhar C |
Mixed signals: cannabinoid system offers new therapeutic possibilities as well as challenges. |
2011 |
Chem. Biol. |
pmid:21609833
|
Blankman JL et al. |
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. |
2007 |
Chem. Biol. |
pmid:18096503
|
Imming P |
Fatty pain cures. |
2007 |
Chem. Biol. |
pmid:18096498
|
King AR et al. |
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. |
2007 |
Chem. Biol. |
pmid:18096504
|
Schmid PC et al. |
Alternative pathways of anandamide biosynthesis in rat testes. |
1998 |
Chem. Phys. Lipids |
pmid:9631536
|
Di Scala C et al. |
Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells. |
2017 |
Chem. Phys. Lipids |
pmid:28389107
|
Palmer SL et al. |
Cannabinergic ligands. |
2002 |
Chem. Phys. Lipids |
pmid:12505686
|
Razdan RK and Mahadevan A |
Recent advances in the synthesis of endocannabinoid related ligands. |
2002 |
Chem. Phys. Lipids |
pmid:12505687
|
Kunos G et al. |
The quest for a vascular endothelial cannabinoid receptor. |
2002 |
Chem. Phys. Lipids |
pmid:12505689
|
Wiley JL and Martin BR |
Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. |
2002 |
Chem. Phys. Lipids |
pmid:12505690
|
Schmid HH et al. |
Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. |
2002 |
Chem. Phys. Lipids |
pmid:12505695
|
Cravatt BF and Lichtman AH |
The enzymatic inactivation of the fatty acid amide class of signaling lipids. |
2002 |
Chem. Phys. Lipids |
pmid:12505696
|
Paria BC et al. |
Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. |
2002 |
Chem. Phys. Lipids |
pmid:12505701
|
Sandberg A and Fowler CJ |
Measurement of saturable and non-saturable components of anandamide uptake into P19 embryonic carcinoma cells in the presence of fatty acid-free bovine serum albumin. |
2005 |
Chem. Phys. Lipids |
pmid:15784231
|
Kotsikorou E et al. |
Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55. |
2011 |
Chem. Phys. Lipids |
pmid:21185816
|
Reggio PH and Traore H |
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase. |
2000 |
Chem. Phys. Lipids |
pmid:11106780
|
Howlett AC and Mukhopadhyay S |
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. |
2000 |
Chem. Phys. Lipids |
pmid:11106782
|
Schmid HH |
Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? |
2000 |
Chem. Phys. Lipids |
pmid:11106783
|
Hillard CJ and Jarrahian A |
The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. |
2000 |
Chem. Phys. Lipids |
pmid:11106786
|
Kunos G et al. |
Endocannabinoids as cardiovascular modulators. |
2000 |
Chem. Phys. Lipids |
pmid:11106789
|
Schmid PC et al. |
Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. |
1997 |
Chem. Phys. Lipids |
pmid:9275307
|
Schmid PC et al. |
A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. |
2000 |
Chem. Phys. Lipids |
pmid:10669310
|
Xie S et al. |
Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2. |
2010 |
Chem. Res. Toxicol. |
pmid:21049984
|
Ahn K et al. |
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. |
2008 |
Chem. Rev. |
pmid:18429637
|
Gurney AM et al. |
Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. |
2003 |
Circ. Res. |
pmid:14551239
|
Fernandez-Patron C et al. |
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. |
2000 |
Circ. Res. |
pmid:11029402
|
Bátkai S et al. |
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. |
2004 |
Circulation |
pmid:15451779
|
Hong Z et al. |
Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. |
2006 |
Circulation |
pmid:16982938
|
Alenmyr L et al. |
TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo. |
2011 |
Clin Physiol Funct Imaging |
pmid:21981454
|
Cui N et al. |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin. |
2017 |
Clin Ther |
pmid:28291580
|
Schroeder C et al. |
Circulating endocannabinoid concentrations during orthostatic stress. |
2009 |
Clin. Auton. Res. |
pmid:19756829
|
Vogeser M et al. |
Release of anandamide from blood cells. |
2006 |
Clin. Chem. Lab. Med. |
pmid:16599845
|
Busch L et al. |
Effects of castration on cannabinoid cb receptor expression and on the biological actions of cannabinoid in the parotid gland. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16487271
|
Ruginsk SG et al. |
Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion. |
2013 |
Clin. Exp. Pharmacol. Physiol. |
pmid:23875874
|
Barun S et al. |
Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16173925
|
Mitchell VA et al. |
Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. |
2007 |
Clin. Exp. Pharmacol. Physiol. |
pmid:17880375
|
Tuboly G et al. |
Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level. |
2009 |
Clin. Exp. Pharmacol. Physiol. |
pmid:19018802
|
Dollery C |
Investigative clinical pharmacology. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21862965
|
Zoerner AA et al. |
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21716266
|
Guindon J and Hohmann AG |
The endocannabinoid system and pain. |
2009 |
CNS Neurol Disord Drug Targets |
pmid:19839937
|
Lambert RC et al. |
Modulation of neuronal T-type calcium channels. |
2006 |
CNS Neurol Disord Drug Targets |
pmid:17168746
|
Khanna IK and Alexander CW |
Fatty acid amide hydrolase inhibitors--progress and potential. |
2011 |
CNS Neurol Disord Drug Targets |
pmid:21631410
|
GarcÃa-GarcÃa F et al. |
Sleep-inducing factors. |
2009 |
CNS Neurol Disord Drug Targets |
pmid:19689305
|
Nilsson O et al. |
Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. |
2003 |
Comp. Biochem. Physiol. C Toxicol. Pharmacol. |
pmid:14659458
|
Després JP |
The endocannabinoid system: a new target for the regulation of energy balance and metabolism. |
2007 |
Crit Pathw Cardiol |
pmid:17667864
|
Kadoi Y et al. |
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. |
2005 |
Crit. Care Med. |
pmid:16276190
|
Panagis G et al. |
Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. |
2008 |
Curr Drug Abuse Rev |
pmid:19630731
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Maccarrone M et al. |
Endocannabinoid degradation, endotoxic shock and inflammation. |
2002 |
Curr Drug Targets Inflamm Allergy |
pmid:14561206
|
Guindon J and Beaulieu P |
The role of the endogenous cannabinoid system in peripheral analgesia. |
2009 |
Curr Mol Pharmacol |
pmid:20021453
|
Battista N et al. |
Endocannabinoids and their involvement in the neurovascular system. |
2004 |
Curr Neurovasc Res |
pmid:16185189
|
Cravatt BF and Lichtman AH |
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. |
2003 |
Curr Opin Chem Biol |
pmid:12941421
|
Rice AS |
Cannabinoids and pain. |
2001 |
Curr Opin Investig Drugs |
pmid:11575713
|
Izzo AA et al. |
The gastrointestinal pharmacology of cannabinoids. |
2001 |
Curr Opin Pharmacol |
pmid:11757815
|
Pate DW et al. |
Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. |
1995 |
Curr. Eye Res. |
pmid:8529418
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. |
1999 |
Curr. Med. Chem. |
pmid:10469888
|
Reggio PH |
Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. |
2010 |
Curr. Med. Chem. |
pmid:20166921
|
Di Marzo V and De Petrocellis L |
Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs. |
2010 |
Curr. Med. Chem. |
pmid:20166923
|
Ashton JC et al. |
Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. |
2008 |
Curr. Med. Chem. |
pmid:18537620
|
Dainese E et al. |
Modulation of the endocannabinoid system by lipid rafts. |
2007 |
Curr. Med. Chem. |
pmid:17979719
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Ohno-Shosaku T and Kano M |
Endocannabinoid-mediated retrograde modulation of synaptic transmission. |
2014 |
Curr. Opin. Neurobiol. |
pmid:24747340
|
Di Marzo V et al. |
Endovanilloid signaling in pain. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12139983
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Leweke FM |
Anandamide dysfunction in prodromal and established psychosis. |
2012 |
Curr. Pharm. Des. |
pmid:22716147
|
Di Marzo T et al. |
Endocannabinoids: new targets for drug development. |
2000 |
Curr. Pharm. Des. |
pmid:10903398
|
Palmer SL et al. |
Natural and synthetic endocannabinoids and their structure-activity relationships. |
2000 |
Curr. Pharm. Des. |
pmid:10903399
|
Fowler CJ |
"The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. |
2008 |
Curr. Pharm. Des. |
pmid:18781976
|
Harvey BS et al. |
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability. |
2013 |
Cytokine |
pmid:23706402
|
Harvey BS et al. |
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. |
2014 |
Cytokine |
pmid:24238999
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
Levin M and Mercola M |
Expression of connexin 30 in Xenopus embryos and its involvement in hatching gland function. |
2000 |
Dev. Dyn. |
pmid:10974676
|
Buznikov GA et al. |
A putative 'pre-nervous' endocannabinoid system in early echinoderm development. |
2010 |
Dev. Neurosci. |
pmid:19907129
|